Twice-Yearly Injection Yields Zero HIV Infections for High-Risk Women in Trial
|
The long-acting injectable antiretroviral drug lenacapavir
(Sunlenca) was highly effective in preventing HIV infection in
cisgender women in ... |
Youths 'can lead fight against HIV/AIDS, gender based violence'
The camp included education on sexual and reproductive health, health literacy, HIV , and malaria testing, etc. Adeoye noted the importance of young ... View article...